Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab

BACKGROUND: Branch retinal vein occlusion is a frequent cause of visual loss with currently insufficient treatment options. We evaluate the effect of Bevacizumab (Avastin(®)) treatment in patients with macular edema induced by branch retinal vein occlusion. METHODS: Retrospective analysis of 32 eyes...

Descripción completa

Detalles Bibliográficos
Autores principales: Abegg, Mathias, Tappeiner, Christoph, Wolf-Schnurrbusch, Ute, Barthelmes, Daniel, Wolf, Sebastian, Fleischhauer, Johannes
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566976/
https://www.ncbi.nlm.nih.gov/pubmed/18823536
http://dx.doi.org/10.1186/1471-2415-8-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566976/
https://www.ncbi.nlm.nih.gov/pubmed/18823536
http://dx.doi.org/10.1186/1471-2415-8-18

Ejemplares similares